David A. Palma

2008–2026 年に発表

137
論文数
18,421
被引用数
66
h 指数
131
i10 指数

被引用数

David A. Palma の年別被引用数1981 年: 被引用 1 件1994 年: 被引用 3 件2001 年: 被引用 1 件2008 年: 被引用 4 件2009 年: 被引用 17 件2010 年: 被引用 23 件2011 年: 被引用 33 件2012 年: 被引用 35 件2013 年: 被引用 49 件2014 年: 被引用 92 件2015 年: 被引用 80 件2016 年: 被引用 70 件2017 年: 被引用 79 件2018 年: 被引用 85 件2019 年: 被引用 520 件2020 年: 被引用 932 件2021 年: 被引用 681 件2022 年: 被引用 585 件2023 年: 被引用 386 件2024 年: 被引用 719 件2025 年: 被引用 253 件2026 年: 被引用 7 件1982〜1993 年は被引用が無いため表示していません1995〜2000 年は被引用が無いため表示していません2002〜2007 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,206 件、この内訳の 21.9%中国: 引用元論文 427 件、この内訳の 7.7%カナダ: 引用元論文 396 件、この内訳の 7.2%イタリア: 引用元論文 364 件、この内訳の 6.6%イギリス: 引用元論文 357 件、この内訳の 6.5%オランダ: 引用元論文 296 件、この内訳の 5.4%ドイツ: 引用元論文 294 件、この内訳の 5.3%フランス: 引用元論文 213 件、この内訳の 3.9%オーストラリア: 引用元論文 198 件、この内訳の 3.6%スイス: 引用元論文 197 件、この内訳の 3.6%ベルギー: 引用元論文 156 件、この内訳の 2.8%日本: 引用元論文 133 件、この内訳の 2.4%
0%21.9%その他 23.1%

分野

  • Medicine83.7%
  • Physics and Astronomy7.5%
  • Biochemistry, Genetics and Molecular Biology4.7%
  • Engineering0.9%
  • Health Professions0.8%
  • Computer Science0.7%
  • その他1.7%

トピック

  • Lung Cancer Diagnosis and Treatment10.8%
  • Advanced Radiotherapy Techniques7%
  • Head and Neck Cancer Studies5.1%
  • Lung Cancer Treatments and Mutations4.9%
  • Radiomics and Machine Learning in Medical Imaging4.5%
  • Hepatocellular Carcinoma Treatment and Prognosis4%
  • その他63.7%

共著者

全論文

検索で開く
  1. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet 2019 被引用: 1,859

  2. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 1,270

  3. Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document

    著者: , , , , , , , , , , , , , - Radiotherapy and Oncology 2020 被引用: 655

  4. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 被引用: 1,086

  5. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bret Wehrli, Keith Kwan, David A. Palma - The Lancet Oncology 2019 被引用: 462

  6. Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis

    著者: , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2013 被引用: 674

  7. Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes

    著者: , , , , , , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2022 被引用: 202

  8. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Keith Kwan, David A. Palma - Journal of Clinical Oncology 2022 被引用: 170

  9. Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - BMC Cancer 2019 被引用: 268

  10. Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Yoo, Adrian Mendez, Eric Winquist, Sara Kuruvilla, Paul Stewart, Andrew Warner, Sylvia Mitchell, Jeff Chen, Christina Parker, Bret Wehrli, Keith Kwan, Julie Theurer, Jinka Sathya, J. Alex Hammond, Nancy Read, Varagur Venkatesan, S. Danielle MacNeil, Kevin Fung, Anthony C. Nichols - JAMA Oncology 2022 被引用: 102

  11. Practical Management of Oligometastatic Non–Small-Cell Lung Cancer

    著者: , , , - Journal of Clinical Oncology 2022 被引用: 99

  12. The Dandelion Dilemma Revisited for Oligoprogression: Treat the Whole Lawn or Weed Selectively?

    著者: , , , - Clinical Oncology 2019 被引用: 118

  13. The genomic and evolutionary landscapes of anaplastic thyroid carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Takafumi N. Yamaguchi, Julie Livingstone, Adriana Salcedo, Krupal Patel, Frederick S. Vizeacoumar, Alessandro Datti, Xi Liu, Yuri E. Nikiforov, Robert C. Smallridge, John A. Copland, Laura A. Marlow, Martin Hyrcza, Leigh Delbridge, Stan B. Sidhu, Mark Sywak, Bruce Robinson, Kevin Fung, Farhad Ghasemi, Keith Kwan, S. Danielle MacNeil, Adrian Mendez, David A. Palma, Mohammed Imran Khan, Mushfiq Hassan Shaikh, Kara M. Ruicci, Bret Wehrli, Eric Winquist, John Yoo, Joe S. Mymryk, James W. Rocco, David A. Wheeler, Steve Scherer, Thomas J. Giordano, John W. Barrett, William C. Faquin, Anthony J. Gill, Gary L. Clayman, Paul C. Boutros, Anthony C. Nichols - Cell Reports 2024 被引用: 73

  14. An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , - Clinical Lung Cancer 2014 被引用: 438

  15. Treatment-Related Toxicity in Patients With Early-Stage Non-Small Cell Lung Cancer and Coexisting Interstitial Lung Disease: A Systematic Review

    著者: , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2017 被引用: 161

  16. Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial

    著者: , , , , , , , , , , , , - BMC Cancer 2012 被引用: 309

  17. Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Danielle MacNeil, Adrian Mendez, John Yoo, Kevin Fung, Pencilla Lang, Eric Winquist, David A. Palma, Hedyeh Ziai, Antonio L. Amelio, Shawn Li, Paul C. Boutros, Joe S. Mymryk, Anthony C. Nichols - EBioMedicine 2022 被引用: 38

  18. Radiographic changes after lung stereotactic ablative radiotherapy (SABR) – Can we distinguish recurrence from fibrosis? A systematic review of the literature

    著者: , , , , , , , - Radiotherapy and Oncology 2012 被引用: 230

  19. Artificial Intelligence in Lung Cancer: Bridging the Gap Between Computational Power and Clinical Decision-Making

    著者: , , , , , - Canadian Association of Radiologists Journal 2020 被引用: 48

  20. A Primer on Interstitial Lung Disease and Thoracic Radiation

    著者: , , , , , , , , , - Journal of Thoracic Oncology 2020 被引用: 86

  21. Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis

    著者: , , , , , - Journal of Clinical Oncology 2010 被引用: 478

  22. ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2025 被引用: 77

  23. Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Warner, David A. Palma - International Journal of Radiation Oncology*Biology*Physics 2024 被引用: 36

  24. Oligometastases: Emerging Evidence

    著者: , , - Journal of Clinical Oncology 2022 被引用: 45